noted 50 percent pfizer 80 percent moderna effective preventing covid altogether trial participants received second vaccine day 21 28 waited day 42 longer number outliers small draw definitive conclusions impact prolonging shot regime example 15,208 trial participants received moderna vaccine 81 0.5 percent received outside recommended window not greatest science point 100 percent comfortable booster 35 40 days denny says deferring public health concerns belief right better according paul bieniasz retrovirologist rockefeller university early pandemic little pressure novel coronavirus evolve immune system primed infection microbe easy pickings millions people infected developed antibodies rising prominence virus going evolve response antibodies irrespective